Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells-Reference-Cited by-同舟云学术

Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells

Published:1992-10 Issue:2 Volume:107 Page:539-543
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Hayashi Yasunori,Tanabe Yasuto,Aramori Ichiro,Masu Masayuki,Shimamoto Keiko,Ohfune Yasufumi,Nakanishi Shigetada

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1992.tb12780.x/fullpdf

Reference28 articles.

1. Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction;ABE;J. Biol. Chem.,1992

2. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor mGluR1 in transfected Chinese hamster ovary cells;ARAMORI;Neuron,1992

3. Quisqualate induces suppression of the calcium-dependent potassium current via a mechanism involving G proteins;BASKYS;Can. J. Physiol. Pharmacol.,1990

4. Trans-ACPD depresses synaptic transmission in the hippocampus;BASKYS;Eur. J. Pharmacol.,1991

5. Potassium conductances in hippocampal neurons blocked by excitatory amino-acid transmitters;CHARPAK;Nature,1990

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, Pharmacology, and In Silico Studies of (1S,2S,3S)-2-((S)-Amino(carboxy)methyl)-3-(carboxymethyl)cyclopropane-1-carboxylic Acid (LBG30300): A Picomolar Potency Subtype-Selective mGlu₂ Receptor Agonist;Journal of Medicinal Chemistry;2024-01-03

2. Targeting mGluR group III for the treatment of neurodegenerative diseases;Biomedicine & Pharmacotherapy;2023-12

3. Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions;Pharmacology Biochemistry and Behavior;2023-02

4. Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases;Pharmacology & Therapeutics;2022-11

5. Discovery of Subtype Selective Agonists of the Group II Metabotropic Glutamate Receptors;Contemporary Accounts in Drug Discovery and Development;2022-03-07